These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16792410)

  • 21. Modular Approach to pseudo-Neoclerodanes as Designer κ-Opioid Ligands.
    Sherwood AM; Williamson SE; Crowley RS; Abbott LM; Day VW; Prisinzano TE
    Org Lett; 2017 Oct; 19(19):5414-5417. PubMed ID: 28910112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Kappa-opioid receptor-selective dicarboxylic ester-derived salvinorin A ligands.
    Polepally PR; White K; Vardy E; Roth BL; Ferreira D; Zjawiony JK
    Bioorg Med Chem Lett; 2013 May; 23(10):2860-2. PubMed ID: 23587424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
    Shirota O; Nagamatsu K; Sekita S
    J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antinociceptive and hypothermic effects of Salvinorin A are abolished in a novel strain of kappa-opioid receptor-1 knockout mice.
    Ansonoff MA; Zhang J; Czyzyk T; Rothman RB; Stewart J; Xu H; Zjwiony J; Siebert DJ; Yang F; Roth BL; Pintar JE
    J Pharmacol Exp Ther; 2006 Aug; 318(2):641-8. PubMed ID: 16672569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Salvinorins J from Salvia divinorum: mutarotation in the neoclerodane system.
    Kutrzeba LM; Ferreira D; Zjawiony JK
    J Nat Prod; 2009 Jul; 72(7):1361-3. PubMed ID: 19473009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoclerodanes as atypical opioid receptor ligands.
    Prisinzano TE
    J Med Chem; 2013 May; 56(9):3435-43. PubMed ID: 23548164
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolation and chemical modification of clerodane diterpenoids from Salvia species as potential agonists at the kappa-opioid receptor.
    Li Y; Husbands SM; Mahon MF; Traynor JR; Rowan MG
    Chem Biodivers; 2007 Jul; 4(7):1586-93. PubMed ID: 17638340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
    Valdés LJ
    J Psychoactive Drugs; 1994; 26(3):277-83. PubMed ID: 7844657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. First total synthesis of the neo-clerodane diterpenoid salvinorin F.
    Hagiwara H; Nojima T; Suka Y; Hoshi T; Suzuki T
    Nat Prod Commun; 2011 Mar; 6(3):333-5. PubMed ID: 21485269
    [No Abstract]   [Full Text] [Related]  

  • 31. Palladium-catalyzed transformations of salvinorin A, a neoclerodane diterpene from Salvia divinorum.
    Riley AP; Day VW; Navarro HA; Prisinzano TE
    Org Lett; 2013 Dec; 15(23):5936-9. PubMed ID: 24246026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salvinorins D-F, new neoclerodane diterpenoids from Salvia divinorum, and an improved method for the isolation of salvinorin A.
    Munro TA; Rizzacasa MA
    J Nat Prod; 2003 May; 66(5):703-5. PubMed ID: 12762813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective natural kappa opioid and cannabinoid receptor agonists with a potential role in the treatment of gastrointestinal dysfunction.
    Fichna J; Schicho R; Janecka A; Zjawiony JK; Storr M
    Drug News Perspect; 2009 Sep; 22(7):383-92. PubMed ID: 19890495
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvinorin A: a novel and highly selective kappa-opioid receptor agonist.
    Yan F; Roth BL
    Life Sci; 2004 Oct; 75(22):2615-9. PubMed ID: 15369697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biosynthesis of salvinorin A proceeds via the deoxyxylulose phosphate pathway.
    Kutrzeba L; Dayan FE; Howell J; Feng J; Giner JL; Zjawiony JK
    Phytochemistry; 2007 Jul; 68(14):1872-81. PubMed ID: 17574635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Semisynthesis and Kappa-Opioid Receptor Activity of Derivatives of Columbin, a Furanolactone Diterpene.
    Yilmaz A; Crowley RS; Sherwood AM; Prisinzano TE
    J Nat Prod; 2017 Jul; 80(7):2094-2100. PubMed ID: 28718638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and in vitro evaluation of salvinorin A analogues: effect of configuration at C(2) and substitution at C(18).
    Béguin C; Richards MR; Li JG; Wang Y; Xu W; Liu-Chen LY; Carlezon WA; Cohen BM
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4679-85. PubMed ID: 16777411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
    Piekielna J; Fichna J; Janecka A
    Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salvia divinorum and salvinorin A: an update on pharmacology and analytical methodology.
    Grundmann O; Phipps SM; Zadezensky I; Butterweck V
    Planta Med; 2007 Aug; 73(10):1039-46. PubMed ID: 17628834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
    Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
    Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.